The Comparative Pathology Core is an established Core within the University of Pennsylvania School of Veterinary Medicine that has been integrated into the Abramson Cancer Center (ACC) and is presented as a newly established Shared Resource for NCI approval and CCSG funding. As such, the Core will enable the ACC to fulfill the growing needs of members who are using animal models. Amy Durham, MS, VMD, Diplomate of the American College of Veterinary Pathologists (DACVP) and Assistant Professor in the Department of Pathobiology at the School of Veterinary Medicine, developed and directs the Core. Dr. Durham is a board- certified anatomic veterinary pathologist with considerable experience in animal models of cancer, and has been involved in numerous collaborative research projects with members of the ACC and others throughout the Penn campus. Recognition and accurate interpretation of gross and histopathological lesions in animal models is essential for the success of cancer research. Currently, Core pathologists work with ACC members from multiple Research Programs, including Tumor Biology, Cancer Therapeutics, Breast Cancer, Immunobiology, Radiobiology and Imaging, and Pediatric Oncology. Among the services that have been provided are: mouse phenotyping, comprehensive slide evaluation and interpretation, consultation, autopsy training, and photomicroscopy. Additional services utilize the Core's histology laboratory to provide histopathology slide preparation, as well as special histochemical and immunohistochemical staining. Working with the Facility Director, Dr. Durham, is Dr. Elizabeth Buza, who is the Core's Technical Director and lead pathologist. Dr. Buza has expertise in mouse pathology and additional training in mouse models of disease from Novartis and Jackson Labs, and she has worked with Dr. Durham for several years. There are several board-certified anatomic pathologists who support Drs. Durham and Buza, and are available to provide specialty expertise depending on the investigator's particular needs. They include Dr. Julie Engiles (osteopathology), Dr. Elizabeth Mauldin (dermatopathology), and Dr. Melissa Snchez (oral pathology and immunohistochemistry). The Core currently serves 12 ACC members which, represents a doubling in ACC member usage since the announcement of the Core as an ACC Shared Resource in July 2013. Thus, as cancer research using mouse models continues to expand, Core utilization by ACC members is predicted to grow substantially.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-44
Application #
9836815
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Nicastri, Michael C; Rebecca, Vito W; Amaravadi, Ravi K et al. (2018) Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells. Mol Cell Oncol 5:e1395504
Micallef, Ivana N; Stiff, Patrick J; Nademanee, Auayporn P et al. (2018) Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Biol Blood Marrow Transplant 24:1187-1195
Medvec, Andrew R; Ecker, Christopher; Kong, Hong et al. (2018) Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium. Mol Ther Methods Clin Dev 8:65-74
Acosta, Jonuelle; Wang, Walter; Feldser, David M (2018) Off and back-on again: a tumor suppressor's tale. Oncogene 37:3058-3069
Crisalli, Lisa M; Hinkle, Joanne T; Walling, Christopher C et al. (2018) Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors. Biol Blood Marrow Transplant 24:1203-1208
Mazaleuskaya, Liudmila L; Salamatipour, Ashkan; Sarantopoulou, Dimitra et al. (2018) Analysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS. J Lipid Res 59:564-575
Facompre, Nicole D; Harmeyer, Kayla M; Sahu, Varun et al. (2018) Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer. Oncotarget 9:8985-8998
Rosenfeld, Aaron M; Meng, Wenzhao; Chen, Dora Y et al. (2018) Computational Evaluation of B-Cell Clone Sizes in Bulk Populations. Front Immunol 9:1472
Shroff, Rachna T; Hendifar, Andrew; McWilliams, Robert R et al. (2018) Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation. JCO Precis Oncol 2018:
Fraietta, Joseph A; Lacey, Simon F; Orlando, Elena J et al. (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24:563-571

Showing the most recent 10 out of 1047 publications